Correlation Between 23Andme Holding and Citius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Citius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Citius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Citius Pharmaceuticals, you can compare the effects of market volatilities on 23Andme Holding and Citius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Citius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Citius Pharmaceuticals.
Diversification Opportunities for 23Andme Holding and Citius Pharmaceuticals
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between 23Andme and Citius is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Citius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Pharmaceuticals and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Citius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Pharmaceuticals has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Citius Pharmaceuticals go up and down completely randomly.
Pair Corralation between 23Andme Holding and Citius Pharmaceuticals
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to generate 0.57 times more return on investment than Citius Pharmaceuticals. However, 23Andme Holding Co is 1.75 times less risky than Citius Pharmaceuticals. It trades about -0.21 of its potential returns per unit of risk. Citius Pharmaceuticals is currently generating about -0.27 per unit of risk. If you would invest 481.00 in 23Andme Holding Co on August 31, 2024 and sell it today you would lose (167.00) from holding 23Andme Holding Co or give up 34.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Citius Pharmaceuticals
Performance |
| Timeline |
| 23Andme Holding |
| Citius Pharmaceuticals |
23Andme Holding and Citius Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Citius Pharmaceuticals
The main advantage of trading using opposite 23Andme Holding and Citius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Citius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Pharmaceuticals will offset losses from the drop in Citius Pharmaceuticals' long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Citius Pharmaceuticals vs. X4 Pharmaceuticals | Citius Pharmaceuticals vs. Hookipa Pharma | Citius Pharmaceuticals vs. Mereo BioPharma Group | Citius Pharmaceuticals vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |